🇺🇸 FDA
Patent

US 6126944

Baculovirus expression vectors and recombinant antigens for detecting type-specific antibodies to herpes simplex virus

expired A61PA61P31/12

Quick answer

US patent 6126944 (Baculovirus expression vectors and recombinant antigens for detecting type-specific antibodies to herpes simplex virus) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Oct 03 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P31/12